These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33171607)

  • 1. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.
    Shin SH; Kim HY; Yoon HS; Park WJ; Adams DR; Pyne NJ; Pyne S; Park JW
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Sphingosine Kinase 2 Derived-sphingosine-1-phosphate Ameliorates Psoriasis-like Skin Disease via Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes in Mice.
    Shin SH; Cho KA; Hahn S; Lee Y; Kim YH; Woo SY; Ryu KH; Park WJ; Park JW
    Acta Derm Venereol; 2019 May; 99(6):594-601. PubMed ID: 30834454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis.
    Schwalm S; Beyer S; Hafizi R; Trautmann S; Geisslinger G; Adams DR; Pyne S; Pyne N; Schaefer L; Huwiler A; Pfeilschifter J
    Cell Signal; 2021 Mar; 79():109881. PubMed ID: 33301900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
    McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
    Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
    Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
    J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
    Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
    Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
    Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
    Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
    Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
    Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
    Gao P; Peterson YK; Smith RA; Smith CD
    PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical application of a BCL-2 inhibitor ameliorates imiquimod-induced psoriasiform dermatitis by eliminating senescent cells.
    Zhu H; Jiang J; Yang M; Zhao M; He Z; Tang C; Song C; Zhao M; Akbar AN; Reddy V; Pan W; Li S; Tan Y; Wu H; Lu Q
    J Dermatol Sci; 2024 Aug; 115(2):54-63. PubMed ID: 38960840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo roles of sphingosine kinase 2 during dengue virus infection.
    Al-Shujairi WH; Clarke JN; Davies LT; Pitman MR; Calvert JK; Aloia AL; Pitson SM; Carr JM
    J Gen Virol; 2019 Apr; 100(4):629-641. PubMed ID: 30869582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion.
    Zhao J; Di T; Wang Y; Wang Y; Liu X; Liang D; Li P
    Eur J Pharmacol; 2016 Feb; 772():131-43. PubMed ID: 26738780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis.
    Alvarez P; Augustín JJ; Tamayo E; Iglesias M; Acinas O; Mendiguren MA; Vázquez JA; Genre F; San Segundo D; Merino J; Merino R
    Arthritis Rheumatol; 2020 Sep; 72(9):1547-1558. PubMed ID: 32249544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antrodia cinnamomea Extract Inhibits Th17 Cell Differentiation and Ameliorates Imiquimod-Induced Psoriasiform Skin Inflammation.
    Li MH; Wu HC; Yao HJ; Lin CC; Wen SF; Pan IH
    Am J Chin Med; 2015; 43(7):1401-17. PubMed ID: 26477794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.